Marlous van der Hooft The radiopharmaceutical theranostics field is growing at an unprecedented pace. Scientific breakthroughs are accelerating, and the engineering of new manufacturing plants is in full swing. We see regular announcements of new tracers, new therapies, and new facilities being planned or built. The focus is intense — and rightly so — on the technical and scientific challenges of this exciting field. But as Byron Fitzgerald aptly asked in his recent post: Who will run these facilities? It’s a question that deserves more attention. While the science and engineering are critical, they are only part of the equation. Once the CAPEX is spent and the facility is built, the real work begins: producing reliably, compliantly, and cost-effectively — day after day. This requires more than machines and molecules. It requires people, systems, and culture. At Qualificiency Consulting, this is where our passion lies. We’ve seen too often that operational readiness is underestimated.